<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font28">and </span>
   <span class="font19">with </span>
   <span class="font17">for </span>
   <span class="font16">drug </span>
   <span class="font15">were </span>
   <span class="font14">was </span>
   <span class="font13">The </span>
   <span class="font13">viral </span>
   <span class="font13">cell </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">compounds </span>
   <span class="font13">assay </span>
   <span class="font12">cells </span>
   <span class="font12">{background </span>
   <span class="font12">that </span>
   <span class="font12">VeroE </span>
   <span class="font12">bexarotene </span>
   <span class="font12">[]. </span>
   <span class="font12">load </span>
   <span class="font12">margin </span>
   <span class="font11">reduction </span>
   <span class="font11">{border-style </span>
   <span class="font11">COVID- </span>
   <span class="font11">anti-SARS-CoV- </span>
   <span class="font11">from </span>
   <span class="font11">px;} </span>
   <span class="font11">treatment </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">virus </span>
   <span class="font11">clinical </span>
   <span class="font11">performed </span>
   <span class="font11">screening </span>
   <span class="font11">culture </span>
   <span class="font11">which </span>
   <span class="font11">abiraterone </span>
   <span class="font11">compound </span>
   <span class="font11">coronavirus </span>
   <span class="font11">viability </span>
   <span class="font11">activity </span>
   <span class="font11">four </span>
   <span class="font11">study </span>
   <span class="font11">used </span>
   <span class="font11">(Fig. </span>
   <span class="font11">CPE </span>
   <span class="font11">Hong </span>
   <span class="font11">antiviral </span>
   <span class="font11">infection </span>
   <span class="font11">novel </span>
   <span class="font11">system </span>
   <span class="font11">Î¼M </span>
   <span class="font11">FDA-approved </span>
   <span class="font11">RNA </span>
   <span class="font11">are </span>
   <span class="font11">data </span>
   <span class="font11">each </span>
   <span class="font11">previously </span>
   <span class="font11">replication </span>
   <span class="font11">selected </span>
   <span class="font11">two-tier </span>
   <span class="font10">Fig. </span>
   <span class="font10">[,]. </span>
   <span class="font10">against </span>
   <span class="font10">ahead </span>
   <span class="font10">concentrations </span>
   <span class="font10">exhibited </span>
   <span class="font10">hpi </span>
   <span class="font10">infected </span>
   <span class="font10">patients </span>
   <span class="font10">print] </span>
   <span class="font10">respiratory </span>
   <span class="font10">then </span>
   <span class="font10">Â°C </span>
   <span class="font10">ELISA </span>
   <span class="font10">Kong </span>
   <span class="font10">cetilistat, </span>
   <span class="font10">described </span>
   <span class="font10">diiodohydroxyquinoline, </span>
   <span class="font10">effective </span>
   <span class="font10">followed </span>
   <span class="font10">identified </span>
   <span class="font10">library </span>
   <span class="font10">shown </span>
   <span class="font10">these </span>
   <span class="font10">this </span>
   <span class="font10">Î¼l </span>
   <span class="font10">Infect. </span>
   <span class="font10">acetate, </span>
   <span class="font10">different </span>
   <span class="font10">inhibition </span>
   <span class="font10">number </span>
   <span class="font10">other </span>
   <span class="font10">plates </span>
   <span class="font10">potential </span>
   <span class="font10">px; </span>
   <span class="font10">results </span>
   <span class="font10">severe </span>
   <span class="font10">showed </span>
   <span class="font10">supernatant </span>
   <span class="font10">syndrome </span>
   <span class="font10">vitro </span>
   <span class="font10">{font-family </span>
   <span class="font10">Cetilistat </span>
   <span class="font10">acetate </span>
   <span class="font10">acute </span>
   <span class="font10">after </span>
   <span class="font10">also </span>
   <span class="font10">but </span>
   <span class="font10">disease </span>
   <span class="font10">expression </span>
   <span class="font10">font-size </span>
   <span class="font10">hpi, </span>
   <span class="font10">human </span>
   <span class="font10">incubated </span>
   <span class="font10">inhibitor </span>
   <span class="font10">protein </span>
   <span class="font10">receptor </span>
   <span class="font10">signal </span>
   <span class="font10">standard </span>
   <span class="font10">using </span>
   <span class="font10">&amp;gt;. </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">-well </span>
   <span class="font10">Bexarotene </span>
   <span class="font10">Briefly, </span>
   <span class="font10">MOI </span>
   <span class="font10">SARS-CoV--N </span>
   <span class="font10">SARS-CoV--infected </span>
   <span class="font10">Viral </span>
   <span class="font10">[], </span>
   <span class="font10">addition </span>
   <span class="font10">and/or </span>
   <span class="font10">assay, </span>
   <span class="font10">concentration </span>
   <span class="font10">determined </span>
   <span class="font10">double; </span>
   <span class="font10">drugs </span>
   <span class="font10">established </span>
   <span class="font10">had </span>
   <span class="font10">has </span>
   <span class="font10">hydroxychloroquine, </span>
   <span class="font10">not </span>
   <span class="font10">potent </span>
   <span class="font10">screen </span>
   <span class="font10">Î¼M, </span>
   <span class="font10">Abiraterone </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Elsevier </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">Research </span>
   <span class="font10">These </span>
   <span class="font10">all </span>
   <span class="font10">another </span>
   <span class="font10">antibody </span>
   <span class="font10">approved </span>
   <span class="font10">before </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">chloroquine, </span>
   <span class="font10">demonstrated </span>
   <span class="font10">effects </span>
   <span class="font10">emerging </span>
   <span class="font10">evaluation </span>
   <span class="font10">experiments </span>
   <span class="font10">further </span>
   <span class="font10">have </span>
   <span class="font10">including </span>
   <span class="font10">indicates </span>
   <span class="font10">its </span>
   <span class="font10">logs </span>
   <span class="font10">medium </span>
   <span class="font10">plaque </span>
   <span class="font10">primary </span>
   <span class="font10">solid; </span>
   <span class="font10">than </span>
   <span class="font10">their </span>
   <span class="font10">time </span>
   <span class="font10">treated </span>
   <span class="font10">without </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(A) </span>
   <span class="font10">(B) </span>
   <span class="font10">(C) </span>
   <span class="font10">(EC) </span>
   <span class="font10">(MOI </span>
   <span class="font10">(PubChem </span>
   <span class="font10">(âˆ¼ </span>
   <span class="font10">All </span>
   <span class="font10">CID: </span>
   <span class="font10">Caco </span>
   <span class="font10">Cell </span>
   <span class="font10">CellTiterGloÂ® </span>
   <span class="font10">Diiodohydroxyquinoline </span>
   <span class="font10">Disease </span>
   <span class="font10">Drug </span>
   <span class="font10">Limited, </span>
   <span class="font10">Med. </span>
   <span class="font10">RT-PCR </span>
   <span class="font10">Res. </span>
   <span class="font10">Table </span>
   <span class="font10">This </span>
   <span class="font10">USA) </span>
   <span class="font10">[Epub </span>
   <span class="font10">[[], </span>
   <span class="font10">[]]. </span>
   <span class="font10">about </span>
   <span class="font10">activities </span>
   <span class="font10">analogue </span>
   <span class="font10">any </span>
   <span class="font10">assay. </span>
   <span class="font10">authors </span>
   <span class="font10">being </span>
   <span class="font10">bexarotene, </span>
   <span class="font10">bold </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">cancer </span>
   <span class="font10">centre </span>
   <span class="font10">clinically </span>
   <span class="font10">collection, </span>
   <span class="font10">compounds, </span>
   <span class="font10">compounds. </span>
   <span class="font10">control. </span>
   <span class="font10">courier; </span>
   <span class="font10">cycle </span>
   <span class="font10">cytotoxicity </span>
   <span class="font10">detection </span>
   <span class="font10">dose-dependent </span>
   <span class="font10">dosing </span>
   <span class="font10">em; </span>
   <span class="font10">entry </span>
   <span class="font10">higher </span>
   <span class="font10">identify </span>
   <span class="font10">implications </span>
   <span class="font10">included </span>
   <span class="font10">inhibited </span>
   <span class="font10">levels </span>
   <span class="font10">lipase </span>
   <span class="font10">luminescent </span>
   <span class="font10">maximal </span>
   <span class="font10">modifications </span>
   <span class="font10">most </span>
   <span class="font10">normalized </span>
   <span class="font10">oral </span>
   <span class="font10">peak </span>
   <span class="font10">pt;} </span>
   <span class="font10">qRT-PCR </span>
   <span class="font10">resource </span>
   <span class="font10">robust </span>
   <span class="font10">seeded </span>
   <span class="font10">serum </span>
   <span class="font10">such </span>
   <span class="font10">therefore </span>
   <span class="font10">Î¼L/well </span>
  </p>
 </body>
</html>
